Authors: Nitin Gupta Sanjeev Sharma Tulika Seth Pravas Mishra Manoranjan Mahapatra Suman Kumar Rajan Kapoor Narendra Agarwal
Publish Date: 2011/08/10
Volume: 79, Issue: 6, Pages: 803-805
Abstract
Autoimmune hemolytic anemia is rare in children and infants and steroids are the corner stone of therapy Management of the patients with steroid refractory/dependent disease is difficult Rituximab is being used in the treatment of a variety of autoimmune diseases including Autoimmune hemolytic anemia AIHAespecially in adults but there is scarce data regarding the use of this agent in pediatric AIHA patientsThe authors report two cases of steroid refractory AIHA who responded to rituximab with review the literature of its use in pediatrics
Keywords: